1. Show article details.

    UBS has whistleblower deal in Brazil currency investigation - paper

    Reuters – 7:42 AM ET 07/03/2015

    Swiss lender UBS AG made a whistleblower deal with Brazilian authorities investigating the suspected rigging of Brazil's currency market and will receive no punishment in the case, a local newspaper reported on Friday. The investigation, which involves 15 of the world's largest banks, began following the presentation of evidence by UBS, Valor Economico reported, without naming its sources.

  2. Show article details.

    S&P Downgrades Chicago Board of Education

    SourceMedia Bond Buyer – 7:07 PM ET 07/02/2015

    Standard & Poor’s has dropped the Chicago Board of Education’s general obligation rating two levels to BBB and put it on CreditWatch negative.

  3. Show article details.

    Short, Volatile Week Ends on a Quiet Note

    SourceMedia Bond Buyer – 7:07 PM ET 07/02/2015

    The holiday week started off with a bang for the municipal bond market — with much of the fireworks coming from outside the continental United States. It ended with a whimper, in a quiet trading day before the national holiday marking the birth of a nation.ü

  4. Show article details.

    Muni Investors Eager for Week's Supply

    SourceMedia Bond Buyer – 7:07 PM ET 07/02/2015

    Municipal bond issuers may find healthy demand for $4.9 billion of deals scheduled in the coming week, as investors look to put reinvestment money to work.

  5. Show article details.

    Munis Steady Ahead of Next Week's Deals

    SourceMedia Bond Buyer – 7:07 PM ET 07/02/2015

    Prices of top-quality municipal bonds were steady at mid-session, traders said, in very quiet pre-holiday trade.

  6. Show article details.

    Muni Market Preps for Holiday, Next Week's New Issues

    SourceMedia Bond Buyer – 7:07 PM ET 07/02/2015

    The municipal bond market is gearing up to take off as the three-day holiday weekend looms large. The bond and stock markets are closed on Friday in observance of the Independence Day holiday. Trading will resume on Monday.

  7. Show article details.

    Negotiated Bond Sales

    SourceMedia Bond Buyer – 7:07 PM ET 07/02/2015

  8. Show article details.

    Results of Competitive Sales

    SourceMedia Bond Buyer – 7:07 PM ET 07/02/2015

    Other managers: CL King& Associates, Crews& Associates, Inc., WNJ Capital, Edward Jones, CastleOak Securities, L.P., Ross, Sinclaire& Associates LLC, Oppenheimer& Co., Inc., Incapital LLC, Sierra Pacific Securities, Wayne Hummer& Co., Bank of New York Mellon Capital Markets, LLC, R. Seelaus& Co., Inc., FTN Financial Capital Markets, Loop Capital Markets, LLC, R H Investment Corp.,...

  9. Show article details.

    Brazil sees no signs local banks joined currency rigging scheme

    Reuters – 4:41 PM ET 07/02/2015

    A probe by Brazil antitrust watchdog Cade on currency market rigging practices since at least 2007 failed to show any signs of the participation of Brazilian banks in the scheme, an official at the agency said on Thursday.

  10. Show article details.

    Vertex's $259,000 Cystic Fibrosis Drug Approved

    DJ Business News – 2:55 PM ET 07/02/2015

    Food and Drug Administration approved Vertex Pharmaceuticals Inc.' s cystic-fibrosis drug Orkambi, which could treat as many as 8,500 patients in the U. S.-but at a whopping annual wholesale cost of $259,000 per patient. The drug, a twice-daily oral tablet for patients 12 years and older, expands the company's reach in the treatment of cystic fibrosis, the progressive lung disease that often kills patients in their 20 s. Vertex said the new drug would be available within days.

  11. Show article details.

    Brazil probes currency market activity of 15 global banks

    Reuters – 2:50 PM ET 07/02/2015

    Fifteen of the world's largest banks are under investigation on suspicion of rigging the Brazilian currency, antitrust watchdog Cade said on Thursday, the first such probe in one of the busiest foreign exchange markets globally.

  12. Show article details.

    Brazil Antitrust Agency Investigating Banks for Suspected Rate Manipulation

    DJ Business News – 11:55 AM ET 07/02/2015

    SAO PAULO-Brazil's antitrust agency is investigating banking giants Citigroup Inc. (C), HSBC Holdings PLC (HSBC), Deutsche Bank AG (DB) and a long list of their peers on suspicion of forming a cartel to manipulate the exchange rate of the Brazilian currency, the real. There are "strong indications" of the use of anticompetitive practices in the foreign-exchange market by the three big banks and 12 other U.S. and overseas lenders, the agency, known as CADE, said Thursday. The agency also named 30...

  13. Show article details.

    Brazil probes currency market activity of 15 global banks

    Reuters – 10:36 AM ET 07/02/2015

    Fifteen of the world's largest banks are under investigation on suspicion of rigging the Brazilian currency, antitrust watchdog Cade said on Thursday, the first such probe in one of the busiest foreign exchange markets globally.

  14. Show article details.

    JP Morgan has 7 pct of Telecom Italia as part of Telefonica bond deal

    Reuters – 8:16 AM ET 07/02/2015

    U.S. investment bank JP Morgan has a 7 percent stake in Telecom Italia as part of a deal with Spain's Telefonica (TEF), according to a filing by Italian market watchdog Consob. Telefonica (TEF) last year issued a 750-million-euro exchangeable bond that converts into Telecom Italia shares and matures in 2017.

  15. Show article details.

    Boom times for healthcare mergers bring bankers 59 percent rise in fees

    Reuters – 7:58 AM ET 07/02/2015

    A surge in mergers and acquisitions in the healthcare sector has been a windfall for investment bankers, with fees from activity in the sector up 59 percent in the first half of 2015, according to Thomson Reuters data. Goldman Sachs (GS) commanded 11.8 percent of all healthcare fees, followed by JP Morgan with 11.2 percent and Morgan Stanley (MS) with 6.9 percent.

  16. Show article details.

    JPMorgan Chase Announces Adjustment to Warrant Exercise Price

    Business Wire – 2:00 AM ET 07/02/2015

    JPMorgan Chase & Co. (JPM) announced today that in accordance with the terms of the outstanding warrants to purchase common stock of JPMorgan Chase (JPM), the warrant Exercise Price will be reduced to $42.325 per share from $42.363 per share, effective as of the close of business on July 6, 2015.

  17. Show article details.

    Chicago Schools Strain to Make Pension Payment

    SourceMedia Bond Buyer – 7:08 PM ET 07/01/2015

    Chicago and school officials plan Wednesday to lay out a comprehensive, long-term plan to address the pension and funding inequities for Illinois' schools.

  18. Show article details.

    Vernon, Calif., to Price $110M

    SourceMedia Bond Buyer – 7:07 PM ET 07/01/2015

    Vernon, Calif., an industrial Los Angeles-area city, plans to issue $110 million in taxable electric revenue bonds for interest rate savings and to eliminate exposure to interest rate swaps.

  19. Show article details.

    JPMorgan Chase Announces Adjustment to Warrant Exercise Price

    Business Wire – 4:34 PM ET 07/01/2015

    JPMorgan Chase & Co. (JPM) announced today that in accordance with the terms of the outstanding warrants to purchase common stock of JPMorgan Chase (JPM), the warrant Exercise Price will be reduced to $42.325 per share from $42.363 per share, effective as of the close of business on July 6, 2015.

  20. Show article details.

    Ranks of commodities brokers dwindle as U.S. futures industry evolves

    Reuters – 1:44 PM ET 07/01/2015

    (For more Reuters coverage of recent changes in futures trading, please see "Chicago Pits: End of an Era," By John McCrank. U.S. commodities brokerages - a key focus of reforms designed to make the financial system safer - are increasingly struggling to eke out a profit, spurring many firms to think about leaving the business, or trying to boost commissions.

Page:

Today's and Upcoming Events

  • Jul
    14

    JPM to announce Q2 earnings Before Market (Confirmed)

  • Jul
    14

    JPM Earnings Conference Call at 8:30 AM Listen

Past Events (last 90 days)

  • Jul
    1

    JPM ex-Dividend for $0.44 on 7/1/2015

    • Announce Date: 5/19/2015
    • Record Date: 7/6/2015
    • Pay Date: 7/31/2015
  • May
    19

    Shareholders Meeting

Data provided by Wall Street Horizon, Inc. © 2015

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.